

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News

Phinc & Oncodesign Services
With Oncodesign Services and Phinc, unlocking the power of PBPK prediction and ADMET experimentation for a better drug development!

Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms
Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!

Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models
This study investigated in vivosynergism between eribulin and palbociclib in a breastcancer patient-derived xenograft (PDX) model.

Oncodesign Services Acquires ZoBio
Acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery, by Oncodesign Services.

Oncolytic Virus Research
Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.

How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate
In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.

Navigating from molecules to medicines in our chemistry department
Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?
Olivier Duchamp discusses the development of new anti-inflammatory strategies for the prevention and treatment of cancer using a better modeling

Breast cancer awareness month
To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.

Targeted RNA degradation: Principle and Therapeutic Promises
RNA, or RiboNucleic Acid, is a structured macromolecule which plays a central role in numerous cellular functions.